Mackenzie Financial Corp Buys 417,651 Shares of Nektar Therapeutics (NASDAQ:NKTR)
Mackenzie Financial Corp lifted its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 801.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 469,769 shares of the biopharmaceutical company’s stock after purchasing an additional 417,651 shares during the period. […]
Mackenzie Financial Corp lifted its stake in Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 801.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 469,769 shares of the biopharmaceutical company’s stock after purchasing an additional 417,651 shares during the period. […]
